The goal of this submission is to describe how and when to best use hemostats, sealants, and adhesives as well as to compare their characteristics and to update the surgical toolbox with respect to any new products approved by the Food and Drug Administration (FDA) as of this date (November 2009). The materials will be presented in 3 major groups each containing specific categories: (1) hemostats; mechanical, active, flowable, and fibrin sealant, (2) sealants; fibrin sealant, polyethylene glycol polymer, and albumin and glutaraldehyde, (3) adhesives; cyanoacrylate, albumin and glutaraldehyde, and fibrin sealant. The categories will be used for comparisons based on safety, efficacy, usability, and cost. Recommendations with respect to how and when to best use these materials will be presented. A review of the recent literature is also provided with respect to the most recent uses of these materials in specific surgical specialties.
Spotnitz WD, Burks S.Hemostats, sealants, and adhesives: components of the surgical toolbox. Transfusion. 2008;48(7): 1502-1516.
2.
Vistarini N. , Aiello M., Mattiucci G., et al. Port-access minimally invasive surgery for atrial septal defects: a 10-year single-center experience in 166 patients . J Thorac Cardiovasc Surg.2010; 139(1):139-145.
3.
Murphy GJ, Reeves BC, Rogers CA, Rizvi SI, Culliford L., Angelini GDIncreased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation . 2007;116(22):2523-2524.
4.
Larsen K., Hansen TB, Thomsen PB, Christiansen T., Søballe K.Cost-effectiveness of accelerated perioperative care and rehabilitation after total hip and knee arthroplasty. J Bone Joint Surg Am.2009;91(4):761-772.
Surgicel, Surgical Fibrillar, and Surgicel Nu-Knit [package insert]. Somerville, NJ: Johnson & Johnson; 2005.
8.
Wagner WR, Pachence JM, Ristich J., Johnson PCComparative in vitro analysis of topical hemostatic agents. J Surg Res. 1996; 66(2):100-108.
9.
Coln D., Horton J., Ogden ME, Buja LMEvaluation of hemostatic agents in experimental splenic lacerations. Am J Surg. 1983; 145(2):256-259.
10.
Murat FJ, Ereth MH, Dong Y., Piedra MP, Gettman MTEvaluation of microporous polysaccharide hemospheres as a novel hemostatic agent in open partial nephrectomy: favorable experimental results in the porcine model. J Urol. 2004;172(3): 1119-1122.
11.
Schenk WG III , Goldthwaite CA Jr, Burks S., Spotnitz WDFibrin sealant facilitates hemostasis in arteriovenous polytetrafluoroethylene grafts for renal dialysis access. Am Surg. 2002;68(8): 728-732.
12.
Thrombin -JMI [package insert]. Bristol, TN: King Pharmaceutical; 2007.
13.
Evithrom [package insert]. Somerville, NJ: Johnson & Johnson; 2007.
Chapman WC, Singla N., Genyk Y., et al. A phase 3, randomized, double-blind comparative study of the efficacy and safety of topical recombinant human thrombin and bovine thrombin in surgical hemostasis. J Am Coll Surg. 2007 ;205(2): 256-265.
Cheng CM, Meyer-Massetti C., Kayser SRA review of three stand-alone topical thrombins for surgical hemostasis. Clin Ther.2009;31(1):32-41.
18.
Oz MC, Cosgrove DM III, Badduke BR, et al. Controlled clinical trial of a novel hemostatic agent in cardiac surgery. The Fusion Matrix Study Group. Ann Thorac Surg. 2000;69(5):1376-1382.
19.
Weaver FA, Hood DB, Zatina M., Messina L., Badduke B.Gelatin-thrombin-based hemostatic sealant for intraoperative bleeding in vascular surgery. Ann Vasc Surg. 2002;16(3):286-293.
Surgiflo [package insert]. Somerville, NJ : Johnson & Johnson; 2006.
22.
Tisseel [package insert]. Westlake Village, CA: Baxter; 2009.
23.
Evicel [package insert]. Somerville, NJ: Johnson & Johnson; 2008.
24.
Wang GJ, Goldthwaite CA Jr, Burks SG, Spotnitz WDExperience improves successful use of fibrin sealant in total knee arthroplasty: implications for surgical education. J Long Term Eff Med Implants . 2003;13(5):389-397.
Fürst W., Banerjee A.Release of glutaraldehyde from an albumin-glutaraldehyde tissue adhesive causes significant in vitro and in vivo toxicity. Ann Thorac Surg. 2005;79(5):1522-1528.
29.
Lemaire SA, Ochoa LN, Conklin LD, et al. Nerve and conduction tissue injury caused by contact with BioGlue . J Surg Res. 2007; 143(2):286-293.
30.
LeMaire SA, Carter SA, Won T., Wang X., Conklin LD, Coselli JSThe threat of adhesive embolization: BioGlue leaks through needle holes in aortic tissue and prosthetic grafts. Ann Thorac Surg. 2005;80(1):106-110.
31.
LeMaire SA, Schmittling ZC, Coselli JS, et al. BioGlue surgical adhesive impairs aortic growth and causes anastomotic strictures. Ann Thorac Surg. 2002;73(5):1500-1505.
32.
Bavaria JE, Brinster DR, Gorman RC, Woo YJ, Gleason T., Pochettino A.Advances in the treatment of acute type A dissection: an integrated approach . Ann Thorac Surg. 2002;74(5): S1848-S1852.
33.
Coselli JS, Bavaria JE, Fehrenbacher J., Stowe CL, Macheers SK, Gundry SRProspective randomized study of a protein-based tissue adhesive used as hemostatic and structural adjunct in cardiac and vascular anastomotic repair procedures . J Am Coll Surg. 2003;197(2):243-252.
34.
Dragu A., Unglaub F., Schwarz S., et al. Foreign body reaction after usage of tissue adhesives for skin closure: a case report and review of the literature. Arch Orthop Trauma Surg.2009;129(2):167-169.
35.
Dermabond High Viscosity [package insert]. Somerville, NJ: Johnson & Johnson; 2003.
36.
Singer AJ, Perry LC, Allen RL Jr.In vivo study of wound bursting strength and compliance of topical skin adhesives . Acad Emerg Med. 2008;15(12):1290-1294.
37.
Artiss [package insert]. Westlake Village, CA: Baxter; 2008.
38.
Hoffmann NE , Siddiqui SA, Agarwal S., et al. Choice of hemostatic agent influences adhesion formation in a rat cecal adhesion model. J Surg Res.2009;155(1):77-81.
39.
Adams GL, Manson RJ, Hasselblad V., Shaw LK, Lawson JHAcute in-vivo evaluation of bleeding with Gelfoam plus saline and Gelfoam plus human thrombin using a liver square lesion model in swine. J Thromb Thrombolysis.2009;28(1):1-5.
40.
Leixnering M., Reichetseder J., Schultz A., et al. Gelatin thrombin granules for hemostasis in a severe traumatic liver and spleen rupture model in swine. J Trauma. 2008;64(2):456-461.
41.
Novik B., Hagedorn S., Mörk UB, Dahlin K., Skullman S., Dalenbäck J.Fibrin glue for securing the mesh in laparoscopic totally extraperitoneal inguinal hernia repair: a study with a 40-month prospective follow-up period . Surg Endosc. 2006;20(3): 462-467.
42.
Fortelny RH , Schwab R., Glaser KS, et al. The assessment of quality of life in a trial on lightweight mesh fixation with fibrin sealant in transabdominal preperitoneal hernia repair. Hernia. 2008; 12(5):499-505.
43.
Ceccarelli G., Casciola L., Pisanelli MC, et al. Comparing fibrin sealant with staples for mesh fixation in laparoscopic transabdominal hernia repair: a case control-study . Surg Endosc. 2008;22(3): 668-673.
44.
Schug-Pass C., Lippert H., Köckerling F.Mesh fixation with fibrin glue (Tissucol/Tisseel(R)) in hernia repair dependent on the mesh structure-is there an optimum fibrin-mesh combination?-Investigations on a biomechanical model. Langenbecks Arch Surg. (IN PRESS).
45.
Fortelny RH , Petter-Puchner AH,Glaser KS, et al. Fibrin sealant (Tisseel) for hiatal mesh fixation in an experimental model in pigs. J Surg Res . (IN PRESS).
46.
Zehetner J. , Lipham JC, Ayazi S., et al. A simplified technique for intrathoracic stomach repair: laparoscopic fundoplication with Vicryl mesh and BioGlue crural reinforcement. Surg Endosc.2010;24(3):675-679.
Fingerhut A. , Veyrie N., Ata T., Alexakis N., Leandros E.Use of sealants in pancreatic surgery: critical appraisal of the literature. Dig Surg.2009 ;26(1):7-14.
49.
Fisher WE, Chai C., Hodges SE, Wu MF, Hilsenbeck SG, Brunicardi FCEffect of BioGlue on the incidence of pancreatic fistula following pancreas resection. J Gastrointest Surg. 2008; 12(5):882-890.
50.
Lämsä T., Jin HT, Sand J., Nordback I.Tissue adhesives and the pancreas: biocompatibility and adhesive properties of 6 preparations. Pancreas. 2008;36(3):261-266.
51.
Henkel A., Cooper RA, Ward KA, Bova D., Yao K.Malignant-appearing microcalcifications at the lumpectomy site with the use of FloSeal hemostatic sealant. AJR Am J Roentgenol. 2008; 191(5):1371-1373.
52.
Zhibo X., Miaobo Z.Effect of sustained-release lidocaine on reduction of pain after subpectoral breast augmentation. Aesthet Surg J. ;200929(1):32-34.
53.
Taflampas P. , Sanidas E., Christodoulakis M., Askoxylakis J., Melissas J., Tsiftsis DDSealants after axillary lymph node dissection for breast cancer: good intentions but bad results. Am J Surg.2009;198(1):55-58.
54.
Athanassiou E., Vamvakopoulos N., Nakopoulou F., et al. Use of albumin polymers during breast cancer surgery improves postoperative seroma outcome. Surg Technol Int. 2009;18:109-116.
55.
Greenhalgh DG, Gamelli RL, Collins J., et al. Recombinant thrombin: safety and immunogenicity in burn wound excision and grafting. J Burn Care Res.2009;30(3):371-379.
56.
Doria C., Fischer CP, Wood CG, Li PM, Marra S., Hart J.Phase 3, randomized, double-blind study of plasma-derived human thrombin versus bovine thrombin in achieving hemostasis in patients undergoing surgery. Curr Med Res Opin. 2008;24(3):785-794.
57.
Nasso G., Piancone F., Bonifazi R., et al. Prospective, randomized clinical trial of the FloSeal matrix sealant in cardiac surgery. Ann Thorac Surg.2009;88(5):1520-1526.
58.
Minato N., Katayama Y., Yunoki J., Kawasaki H., Satou H.Hemostatic effectiveness of a new application method for fibrin glue, the ‘‘rub-and-spray method,’’ in emergency aortic surgery for acute aortic dissection. Ann Thorac Cardiovasc Surg.2009; 15(4):265-271.
59.
Napoleone CP , Valori A., Crupi G., Ocello S., Santoro F., Vouhé P., Weerasena N., Gargiulo G.An observational study of CoSeal(R) for the prevention of adhesions in pediatric cardiac surgery. Interact Cardiovasc Thorac Surg.2009;9(6):978-982.
60.
Pätilä T., Jokinen JJ, Salminen J., Kankuri E., Harjula A.Polyglycolic acid glue does not prevent intrapericardial adhesions in a short-term follow-up. J Surg Res. 2008;148(2):181-184.
61.
Yu J., Christman KL, Chin E., Sievers RE, Saeed M., Lee RJRestoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy. J Thorac Cardiovasc Surg.2009;137(1): 180-187.
62.
Krishnamoorthy B., Najam O., Khan UA, Waterworth P., Fildes JE, Yonan N.Randomized prospective study comparing conventional subcuticular skin closure with Dermabond skin glue after saphenous vein harvesting . Ann Thorac Surg.2009; 88(5):1445-1449.
63.
Azadani AN, Matthews PB, Ge L., et al. Mechanical properties of surgical glues used in aortic root replacement. Ann Thorac Surg.2009;87(4):1154-1160.
64.
Goldberg SP , Campbell DNMechanical aortic valve dysfunction due to biological glue. Ann Thorac Surg.2009;88(2):671-672.
65.
Cavolli R., Kaya K., Elalmis AO‘‘Acute pseudo-pericardial tamponade’’: the compression of the thoracal inferior vena cava-a case report. J Cardiothorac Surg.2009;4(1):9.
66.
Testini M., Marzaioli R., Lissidini G., et al. The effectiveness of FloSeal matrix hemostatic agent in thyroid surgery: a prospective, randomized, control study. Langenbecks Arch Surg.2009;394(5): 837-842.
67.
Woodworth BA, Chandra RK, LeBenger JD, Ilie B., Schlosser RJA gelatin-thrombin matrix for hemostasis after endoscopic sinus surgery. Am J Otolaryngol.2009;30(1):49-53.
68.
Antisdel JL, Janney CG, Long JP, Sindwani R.Hemostatic agent microporous polysaccharide hemospheres (MPH) does not affect healing or intact sinus mucosa. Laryngoscope. 2008;118(7): 1265-1269.
69.
Vaiman M., Sarfaty S., Eviatar E.The use of fibrin sealant as a glue for septoplasty and conchotomy. Rhinology.2009;47(3): 297-300.
70.
Bozkurt MK, Saydam L.The use of cyanoacrylates for wound closure in head and neck surgery. Eur Arch Otorhinolaryngol. 2008;265(3):331-335.
71.
Greenhill GA , O’Regan B.Incidence of hypertrophic and keloid scars after N-butyl 2-cyanoacrylate tissue adhesive had been used to close parotidectomy wounds: a prospective study of 100 consecutive patients. Br J Oral Maxillofac Surg. 2009; 47(4):290-293.
72.
Reich W., Kriwalsky MS, Wolf HH, Schubert J.Bleeding complications after oral surgery in outpatients with compromised haemostasis: incidence and management. Oral Maxillofac Surg.2009;13(2):73-77.
73.
Ereth MH, Schaff M., Ericson EF, Wetjen NM, Nuttall GA, Oliver WC Jr.Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model. Neurosurgery. 2008; 63(4 suppl 2):369-372.
74.
Gazzeri R., Galarza M., Neroni M., Alfieri A., Esposito S.Minimal craniotomy and matrix hemostatic sealant for the treatment of spontaneous supratentorial intracerebral hemorrhage. J Neurosurg.2009;110(5):939-942.
75.
Dogulu F., Durdag E., Cemil B., Kurt G., Ozgun G.The role of FloSeal in reducing epidural fibrosis in a rat laminectomy model . Neurol Neurochir Pol.2009;43(4):346-351.
76.
Ferschl MB, Rollins MDThromboemboli, acute right heart failure and disseminated intravascular coagulation after intraoperative application of a topical hemostatic matrix. Anesth Analg.2009;108(2):434-436.
77.
Buchowski JM , Bridwell KH, Lenke LG, Good CREpidural spinal cord compression with neurologic deficit associated with intrapedicular application of hemostatic gelatin matrix during pedicle screw insertion. Spine ( Phila Pa1976). 2009;34(13): E473-E477.
78.
Blackburn SL , Smyth MDHydrogel-induced cervicomedullary compression after posterior fossa decompression for Chiari malformation. Case report. J Neurosurg. 2007;106(4 suppl): 302-304.
79.
Mulder M., Crosier J., Dunn R.Cauda equina compression by hydrogel dural sealant after a laminotomy and discectomy: case report. Spine (Phila Pa1976). 2009;34(4):E144-E148.
80.
Than KD, Baird CJ, Olivi A.Polyethylene glycol hydrogel dural sealant may reduce incisional cerebrospinal fluid leak after posterior fossa surgery. Neurosurgery. 2008;63(1 suppl 1): ONS182-ONS6.
81.
Leng LZ, Brown S., Anand VK, Schwartz TH‘‘Gasket-seal’’ watertight closure in minimal-access endoscopic cranial base surgery. Neurosurgery. 2008;62(5 suppl 2): ONSE342-ONSE343.
82.
Hohendorff B., Siepen W., Spiering L., Staub L., Schmuck T., Boss A.Long-term results after operatively treated Achilles tendon rupture: fibrin glue versus suture. J Foot Ankle Surg. 2008; 47(5):392-399.
83.
Ebert AD, Hollauer A., Fuhr N., Langolf O., Papadopoulos T.Laparoscopic ovarian cystectomy without bipolar coagulation or sutures using a gelantine-thrombin matrix sealant (FloSeal): first support of a promising technique. Arch Gynecol Obstet.2009; 280(1):161-165.
84.
Angioli R., Muzii L., Montera R., et al. Feasibility of the use of novel matrix hemostatic sealant (FloSeal) to achieve hemostasis during laparoscopic excision of endometrioma. J Minim Invasive Gynecol.2009;16(2):153-156.
85.
Raga F., Sanz-Cortes M., Bonilla F., Casañ EM, Bonilla-Musoles F.Reducing blood loss at myomectomy with use of a gelatin-thrombin matrix hemostatic sealant. Fertil Steril. 2009;92(1): 356-360.
86.
Mettler L., Hucke J., Bojahr B., Tinneberg HR, Leyland N., Avelar R.A safety and efficacy study of a resorbable hydrogel for reduction of post-operative adhesions following myomectomy. Hum Reprod. 2008;23(5):1093-1100.
87.
Panda A., Kumar S., Kumar A., Bansal R., Bhartiya S.Fibrin glue in ophthalmology. Indian J Ophthalmol.2009;57(5):371-379.
88.
Osaki TH, Osaki MH, Belfort R. Jr, Osaki T., Sant’anna AE, Haraguchi DKManagement of progressive myopathic blepharoptosis with daily application of octyl-2-cyanoacrylate liquid bandage. Ophthal Plast Reconstr Surg. 2009;25(4):264-266.
89.
Kitagawa K. , Yanagisawa S., Watanabe K., et al. A hyperdry amniotic membrane patch using a tissue adhesive for corneal perforations and bleb leaks. Am J Ophthalmol.2009;148(3):383-389.
90.
Nipshagen MD , Hage JJ, Beekman WHUse of 2-octyl-cyanoacrylate skin adhesive (Dermabond) for wound closure following reduction mammaplasty: a prospective, randomized intervention study. Plast Reconstr Surg. 2008;122(1):10-18.
91.
Wilson AD, Mercer N.Dermabond tissue adhesive versus Steri-Strips in unilateral cleft lip repair: an audit of infection and hypertrophic scar rates. Cleft Palate Craniofac J. 2008;45(6):614-619.
92.
Perin LF, Helene A. Jr, Fraga MFSutureless closure of the upper eyelids in blepharoplasty: use of octyl-2-cyanoacrylate . Aesthet Surg J.2009;29(2):87-92.
93.
Moser C., Opitz I., Zhai W., et al. Autologous fibrin sealant reduces the incidence of prolonged air leak and duration of chest tube drainage after lung volume reduction surgery: a prospective randomized blinded study. J Thorac Cardiovasc Surg. 2008;136(4): 843-849.
94.
D’Andrilli A., Andreetti C., Ibrahim M., et al. A prospective randomized study to assess the efficacy of a surgical sealant to treat air leaks in lung surgery . Eur J Cardiothorac Surg. 2009;35(5): 817-820.
95.
Ranu H., Gatheral T., Sheth A., Smith EE, Madden BPSuccessful endobronchial seal of surgical bronchopleural fistulas using BioGlue . Ann Thorac Surg.2009;88(5):1691-1692.
96.
Nogueira L., Katz D., Pinochet R., Kurta JM, Coleman JAComparison of gelatine matrix-thrombin sealants used during laparoscopic partial nephrectomy. BJU Int. 2008;102(11): 1670-1674.
97.
Ho H., Schwentner C., Neururer R., Steiner H., Bartsch G., Peschel R.Robotic-assisted laparoscopic partial nephrectomy: surgical technique and clinical outcomes at 1 year. BJU Int. 2009 ;103(7):663-668.
98.
Derweesh IH, Malcolm JB, Diblasio CJ, Mehrazin R., Jackson S.Sutureless laparoscopic heminephrectomy: safety and efficacy in physiologic and chronically obstructed porcine kidney. Surg Innov. 2008;15(3):194-202.
99.
Björses K., Holst J.Topical haemostatics in renal trauma-an evaluation of four different substances in an experimental setting. J Trauma.2009;66(3):602-611.
100.
Weaver FA, Lew W., Granke K., Yonehiro L., Delange B., Alexander WA; Study Investigators.A comparison of recombinant thrombin to bovine thrombin as a hemostatic ancillary in patients undergoing peripheral arterial bypass and arteriovenous graft procedures. J Vasc Surg. 2008;47(6):1266-1273.
101.
Hanson JM, Atri M., Power N.Ultrasound-guided thrombin injection of iatrogenic groin pseudoaneurysm: doppler features and technical tips. Br J Radiol. 2008;81(962):154-63.
